News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 6:59:54 pm ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023 InvestorPlace
2024-03-07 1:1:0 pm Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results GlobeNewswire
2024-02-29 1:5:0 pm Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results GlobeNewswire
2024-02-06 1:30:0 pm Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference GlobeNewswire
2024-02-01 6:0:0 am Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
2024-01-08 6:0:0 am Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer GlobeNewswire
2024-01-04 6:0:0 am Oncternal Therapeutics Announces Reverse Stock Split GlobeNewswire
2023-12-26 6:0:0 am Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information